posit mitig raw inflat
downgrad ebitda reduc target price
maintain outperform rate estim symris sustain margin
mid-high singl digit organ growth beyond
backward integr raw materi ramp-up signific new capac
continu cost optim believ market overli concern
near-term temporari raw materi inflat creat attract
buy opportun share
place mitig rise raw estim raw materi
basf citral outag
aromas/menthol vanilla shortag elev petrochem price
howev believ symris well posit mitig impact
back integr raw materi place
favour negoti posit custom vs name
requir larger price increas forecast volum
price flat margin yoy estim small margin weak
lag price increas higher production/freight cost follow full
price recoveri normal raw materi environ
spot price driven
invest set acceler growth forecast volum
growth acceler major invest project
ramp cosmet food menthol estim cumul growth
contribut six major project invest ramp
support mid-high singl digit organ growth mid-term
valuat target price averag peer multipl
dcf key risk outperform rate cost
inflat beyond expect
valuat metric
price month
price rel chart measur perform
deutsch bors dax close
spot exchang rate
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
symris global provid fragranc flavor activ
ingredi aroma chemic well sensori nutrit
solut perfum cosmet pharmaceut food beverag
pet food babi food industri
price rate outperform target price analyst mathew hampshire-waugh
profit tax
associ
chang work capit
cash non-cash item
flow oper
free cash-flow firm
flow invest
issuanc retir debt
cash-flow financ
chang net cash/debt
digit growth ebitda multipl compar base
case scenario top-line growth ebitda margin
digit growth ebitda multipl compar base
case scenario top-line growth ebitda margin
price rel chart measur perform deutsch
bors dax close
spot exchang rate
net debt start
chang net debt
net debt end
total equiti liabil
share wtd average mn
ratio valuat
net debt ebitda
lower forecast ebitda due fx small margin compress
scent reduc ebitda driven fx temporari margin
pressur forecast margin pressur higher
product cost manufactur aroma suppli basf freight cost
ship product altern sourc yet compens higher price
expect price increas compens implement lag
quarter basf outag start fy forecast
volum price fx headwind forecast flat margin
pressur fulli recov
flavour nutrit reduc ebitda driven mostli updat fx
headwind acquisit forecast small margin increas yoy
driven synergi recent acquisit smaller headwind probi
forecast organ earn growth driven organ revenu
growth non-organ item follow
cobel acquisit assum addit month cobel
improv margin
fx headwind weaker usd
new invest includ contribut pet food franc flavour
usa cosmet usa equat ebitda normal run-
renessenz/pinova synergi synergi
sale pinova industri
nutraceutix probi acquisit
new invest
symris trade consensu month forward ev/ebitda discount peer
discount year averag trade line month forward price-to-earnings
basi symris current trade premium peer discount year
peer averag euro stoxx rel
compani mention price
